Home LiteratureArticle Details
PMID: 17187665 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

A common genetic factor for Parkinson disease in ethnic Chinese population in Taiwan.

BMC neurology ·Vol. 6 ·2006-12-22 ·Pages 47

Fung HC, Chen CM, Hardy J, Singleton AB, Wu YR

Abstract

Parkinson's disease (PD) is the most common neurodegenerative movement disorder, characterized clinically by resting tremor, bradykinesia, postural instability and rigidity. The prevalence of PD is approximately 2% of the population over 65 years of age and 1.7 million PD patients (age > or = 55 years) live in China. Recently, a common LRRK2 variant Gly2385Arg was reported in ethnic Chinese PD population in Taiwan. We analyzed the frequency of this variant in our independent PD case-control population of Han Chinese from Taiwan. 305 patients and 176 genetically unrelated healthy controls were examined by neurologists and the diagnosis of PD was based on the published criteria. The region of interest was amplified with standard polymerase chain reaction (PCR). PCR fragments then were directly sequenced in both forward and reverse directions. Differences in genotype frequencies between groups were assessed by the X2 test, while X2 analysis was used to test for the Hardy-Weinberg equilibrium. Of the 305 patients screened we identified 27 (9%) with heterozygous G2385R variant. This mutation was only found in 1 (0.5%) in our healthy control samples (odds ratio = 16.99, 95% CI: 2.29 to 126.21, p = 0.0002). Sequencing of the entire open reading frame of LRRK2 in G2385R carriers revealed no other variants. These data suggest that the G2385R variant contributes significantly to the etiology of PD in ethnic Han Chinese individuals. With consideration of the enormous and expanding aging Chinese population in mainland China and in Taiwan, this variant is probably the most common known genetic factor for PD worldwide.

MeSH Terms
Adult Aged Aged, 80 and over Asians/genetics,statistics & numerical data DNA Mutational Analysis Female Genetic Predisposition to Disease/epidemiology,genetics Genetic Testing/methods Humans Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Male Middle Aged Parkinson Disease/ethnology,genetics Polymorphism, Single Nucleotide/genetics Prevalence Protein Serine-Threonine Kinases/genetics Risk Assessment/methods Risk Factors Taiwan/ethnology
Chemicals
LRRK2 protein, human Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Protein Serine-Threonine Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fung Hon-Chung
Department of Neurology, Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, 199 Tung-Hwa North Road, Taipei, 10591, Taiwan. fungp@mail.nih.gov <fungp@mail.nih.gov>
Chen Chiung-Mei
Hardy John
Singleton Andrew B
Wu Yih-Ru
References (13)
13 references, click to expand
  1. LRRK2 mutations in Parkinson disease.
    Neurology. 2005 Sep 13;65(5):738-40 PMID: 16157908
  2. Prevalence of Parkinson's disease in China.
    Lancet Neurol. 2005 Jun;4(6):328-9 PMID: 15907734
  3. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.
    Neuron. 2004 Nov 18;44(4):601-7 PMID: 15541309
  4. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.
    Neuron. 2004 Nov 18;44(4):595-600 PMID: 15541308
  5. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.
    J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4 PMID: 1564476
  6. Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China.
    Mov Disord. 2003 Jul;18(7):764-72 PMID: 12815655
  7. The LRRK2 Gly2385Arg variant is associated with Parkinson's disease: genetic and functional evidence.
    Hum Genet. 2007 Feb;120(6):857-63 PMID: 17019612
  8. A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson's disease risk in Taiwan.
    Neurogenetics. 2006 Jul;7(3):133-8 PMID: 16633828
  9. Lack of G2019S LRRK2 mutation in a cohort of Taiwanese with sporadic Parkinson's disease.
    Mov Disord. 2006 Jun;21(6):880-1 PMID: 16511860
  10. Lrrk2 pathogenic substitutions in Parkinson's disease.
    Neurogenetics. 2005 Dec;6(4):171-7 PMID: 16172858
  11. How genetics research in Parkinson's disease is enhancing understanding of the common idiopathic forms of the disease.
    Curr Opin Neurol. 2005 Dec;18(6):706-11 PMID: 16280683
  12. The dardarin G 2019 S mutation is a common cause of Parkinson's disease but not other neurodegenerative diseases.
    Neurosci Lett. 2005 Dec 9;389(3):137-9 PMID: 16102903
  13. Kinase activity is required for the toxic effects of mutant LRRK2/dardarin.
    Neurobiol Dis. 2006 Aug;23(2):329-41 PMID: 16750377
Article Info
Journal
BMC neurology
Abbr.
BMC Neurol
ISSN
1471-2377
Published
2006-12-22
Epub
2006-00-22
Pages
47
Language
English
Region
England
NLM ID
100968555
PMCID
PMC1764029
Subset
IM
Grants
Parkinson's UK · G-0907 · United Kingdom
Medical Research Council · G0701075 · United Kingdom
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com